St. Vincent's Institute of Medical Research, Fitzroy, Vic., Australia.
Immunol Rev. 2012 Nov;250(1):277-302. doi: 10.1111/j.1600-065X.2012.01164.x.
Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 are members of a discrete family of cytokines that regulates the growth, differentiation, migration and effector function activities of many hematopoietic cells and immunocytes. These cytokines are involved in normal responses to infectious agents, bridging innate and adaptive immunity. However, in certain cases, the overexpression of these cytokines or their receptors can lead to excessive or aberrant initiation of signaling resulting in pathological conditions, with chronic inflammatory diseases and myeloid leukemias the most notable examples. Recent crystal structures of the GM-CSF receptor ternary complex and the IL-5 binary complex have revealed new paradigms of cytokine receptor activation. Together with a wealth of associated structure-function studies, they have significantly enhanced our understanding of how these receptors recognize cytokines and initiate signals across cell membranes. Importantly, these structures provide opportunities for structure-based approaches for the discovery of novel and disease-specific therapeutics. In addition, recent biochemical evidence has suggested that the GM-CSF/IL-3/IL-5 receptor family is capable of interacting productively with other membrane proteins at the cell surface. Such interactions may afford additional or unique biological activities and might be harnessed for selective modulation of the function of these receptors in disease.
粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素 3(IL-3)和白细胞介素 5(IL-5)是调节许多造血细胞和免疫细胞的生长、分化、迁移和效应功能活动的一类离散细胞因子家族的成员。这些细胞因子参与对感染因子的正常反应,连接先天免疫和适应性免疫。然而,在某些情况下,这些细胞因子或其受体的过度表达会导致信号转导的过度或异常起始,从而导致病理状况,慢性炎症性疾病和髓样白血病是最显著的例子。GM-CSF 受体三元复合物和 IL-5 二元复合物的最近晶体结构揭示了细胞因子受体激活的新范例。结合大量相关的结构功能研究,它们极大地增强了我们对这些受体如何识别细胞因子并在细胞膜内引发信号的理解。重要的是,这些结构为基于结构的方法提供了发现新型和疾病特异性治疗药物的机会。此外,最近的生化证据表明,GM-CSF/IL-3/IL-5 受体家族能够在细胞表面与其他膜蛋白进行有效相互作用。这种相互作用可能提供额外的或独特的生物学活性,并可能被用于选择性调节这些受体在疾病中的功能。